Determination of sirolimus in rabbit arteries using liquid chromatography separation and tandem mass spectrometric detection

Biomedical Chromatography

Volumn 21, Issue 10, 2007, Pages 1036-1044

  Zhang, Jun ^a   Rodila, Ramona ^a   Watson, Pamela ^a   Ji, Qin ^a   El Shourbagy, Tawakol A ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Determination; LC MS MS; Rapamycin; Sirolimus; Tissue

Indexed keywords

BLOOD; CALIBRATION; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; EXTRACTION; HOMOGENIZATION METHOD; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; QUALITY ASSURANCE; QUALITY CONTROL; STENTS; TISSUE ENGINEERING;

CALIBRATION STANDARD; CONTROL SAMPLES; DETERMINATION; HOMOGENIZATION PROCESS; LC-MS-MS; LC.MS/MS; RAPAMYCIN; SIROLIMUS; TISSUE HOMOGENATES; TISSUE QUALITY;

TISSUE;

RAPAMYCIN;

ACCURACY; ANIMAL TISSUE; ARTERY; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG STRUCTURE; DRUG TISSUE LEVEL; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; NONHUMAN; PROCESS OPTIMIZATION; QUALITY CONTROL; RABBIT; SEPARATION TECHNIQUE; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY;

ORYCTOLAGUS CUNICULUS;

EID: 34848895390     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.849     Document Type: Article

References (17)

1. Calne RY, Collier DS, Lim S, Pollard SG, Samaan A, White DJ and Thiru S. Rapamycin for immunosuppression in organ allografting. Lancet 1989; 2: 443-444.
2. Eng CP, Sehgal SN and Vezina C. Activity of rapamycin (AY-22,989) against transplanted tumors. Journal of Antibiotics 1984; 37: 1231-1237.
3. Gallo R, Padurean A, Jayaraman T, Marx S, Roque M, Adelman S, Chesebro J, Fallon J, Fuster V, Marks A and Badimon JJ. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 1999; 99: 2164-2170.
4. Kimball PM, Kerman RH and Kahan BD. Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine. Transplantation 1991; 51: 486-490.
5. Morris RG, Salm P, Taylor PJ, Wicks FA and Theodossi A. Comparison of the reintroduced MEIA assay with HPLC-MS/MS for the determination of whole-blood sirolimus from transplant recipients. Therapeutic Drug Monitoring 2006; 28: 164-168.
6. Napoli KL and Taylor PJ. From beach to bedside: history of the development of sirolimus. Therapeutic Drug Monitoring 21301; 23: 559-586.
7. Pieri M, Miraglia N, Castiglia L, Genovese G, Basilicata P, Simonelli A and Acampora A. Determination of rapamycin: quantification of the sodiated species by an ion trap mass spectrometer as an alternative to the ammoniated complex analysis by triple quadrupole. Rapid Communications in Mass Spectrometry 2005; 19: 3042-3050.
8. Sehgal SN, Baker H and Vezina C. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. Journal of Antibiotics 1975; 28: 727-732.
9. Serruys PW, Regar E and Carter AJ. Rapamycin eluting stent: the onset of a new era in interventional cardiology. Heart 2002; 87: 305-307.
10. Streit F, Armstrong VW and Oellerich M. Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. Clinical Chemistry 2002; 48: 955-958.
11. Vogeser M, Fleischer C, Meiser B, Groetzner J, Spohrer U and Seidel D. Quantification of sirolimus by liquid chromatography-tandem mass spectrometry using on-line solid-phase extraction. Clinical Chemistry and Laboratory Medicine 2002; 40: 40-45.
12. Volosov A, Napoli KL and Soldin SJ. Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography-tandem mass-spectrometry. Clinical Biochemistry 2001; 34: 285-290.
13. Yatscoff R, LeGatt D, Keenan R and Chackowsky P. Blood distribution of rapamycin. Transplantation 1993; 56: 1202-1206.
14. Yatscoff RW, Wang P, Chan K, Hicks D and Zimmerman J. Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations. Therapeutic Drug Monitoring 1995; 17: 666-671.
15. Zhang J, Kim EJ, Ji QC and El-Shourbagy TA. Developing multiple high-throughput GLP methods for an investigational drug candidate in various matrices within a 96-well plate. Rapid Communications in Mass Spectrometry 2006a; 20: 3755-3760.
16. Zhang J, Reimer MT, Alexander NE, Ji QC and El-Shourbagy TA. Method development and validation for zotarolimus concentration determination in stented swine arteries by liquid chromatography/tandem mass spectrometry detection. Rapid Communications in Mass Spectrometry 2006b; 20: 3427-3434.
17. Zhang J, Reimer MT, Ji QC, Chang MS, El-Shourbagy TA, Burke S and Schwartz L. Accurate determination of an immunosuppressant in stented swine tissues with LC-MS/MS. Analytical and Bioanalytical Chemistry 2007; 387: 2745-2756.